Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-02

Clinical Trial Update: HERO-2: Home-Reported Outcomes With CFTR Modulator Therapy

View source ↗

Summary

The HERO-2 trial update reports home-reported outcomes from participants receiving CFTR modulator therapy for cystic fibrosis, and the study has completed. It h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Indiana University | Conditions: Cystic Fibrosis | Status: COMPLETED